Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
Authors
Keywords
Age-related macular degeneration, Diabetic retinopathy, Retinal vein occlusion, Microparticles, Gene transfer
Journal
PROGRESS IN RETINAL AND EYE RESEARCH
Volume 83, Issue -, Pages 100921
Publisher
Elsevier BV
Online
2020-11-26
DOI
10.1016/j.preteyeres.2020.100921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
- (2020) Hiroki Tsujinaka et al. Nature Communications
- Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)
- (2020) Adam R. Glassman et al. OPHTHALMOLOGY
- VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
- (2020) Nicolas Froger et al. Scientific Reports
- Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration
- (2019) E.P. Rakoczy et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema
- (2019) Mustafa Iftikhar et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Choriocapillaris Degeneration in Geographic Atrophy
- (2019) Elliott H. Sohn et al. AMERICAN JOURNAL OF PATHOLOGY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Swept-Source Optical Coherence Tomography for Evaluating the Lamina Cribrosa A Report by the American Academy of Ophthalmology
- (2019) Hana L. Takusagawa et al. OPHTHALMOLOGY
- Low risk to retina from sustained suppression of VEGF
- (2019) Peter A. Campochiaro JOURNAL OF CLINICAL INVESTIGATION
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- Changes in the Anterior Lamina Cribrosa Morphology with Glaucoma Severity
- (2019) Nicholas Y. Q. Tan et al. Scientific Reports
- AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration
- (2018) Yuanyuan Liu et al. MOLECULAR THERAPY
- Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti–VEGF Drug Type for 1 Year in the IRIS Registry
- (2018) Prethy Rao et al. OPHTHALMOLOGY
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
- (2017) Peter A. Campochiaro et al. HUMAN GENE THERAPY
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Plastic roles of pericytes in the blood–retinal barrier
- (2017) Do Young Park et al. Nature Communications
- Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial
- (2016) Peter A. Campochiaro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Anti–Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease
- (2016) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion
- (2016) Tahreem A. Mir et al. OPHTHALMOLOGY
- Regression of Choroidal Neovascularization Results in Macular Atrophy in Anti-Vascular Endothelial Growth Factor-Treated Eyes
- (2015) Roomasa Channa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study
- (2015) Peter A. Campochiaro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Neurovascular crosstalk between interneurons and capillaries is required for vision
- (2015) Yoshihiko Usui et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography
- (2015) Paolo S. Silva et al. OPHTHALMOLOGY
- Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening Retinopathy
- (2015) Michael S. Ip et al. OPHTHALMOLOGY
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- The Membrane Attack Complex in Aging Human Choriocapillaris
- (2014) Robert F. Mullins et al. AMERICAN JOURNAL OF PATHOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Neurons Limit Angiogenesis by Titrating VEGF in Retina
- (2014) Keisuke Okabe et al. CELL
- Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates
- (2014) M A Kotterman et al. GENE THERAPY
- Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature
- (2014) Jikui Shen et al. JOURNAL OF CLINICAL INVESTIGATION
- Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration
- (2014) Antje Biesemeier et al. NEUROBIOLOGY OF AGING
- Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema
- (2014) Yi Zhang et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Neutralization of Vascular Endothelial Growth Factor Slows Progression of Retinal Nonperfusion in Patients with Diabetic Macular Edema
- (2014) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion
- (2013) Raafay Sophie et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma
- (2013) Richard H. Foxton et al. AMERICAN JOURNAL OF PATHOLOGY
- Alterations to vascular endothelium in the optic nerve head in patients with vascular comorbidities
- (2013) Min H. Kang et al. EXPERIMENTAL EYE RESEARCH
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab
- (2013) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death
- (2013) D. S. Welsbie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
- (2013) D. Dalkara et al. Science Translational Medicine
- Exploratory Analysis of the Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial
- (2013) Susan B. Bressler JAMA Ophthalmology
- Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
- (2012) Michael S. Ip ARCHIVES OF OPHTHALMOLOGY
- Targeted deletion of Vegfa in adult mice induces vision loss
- (2012) Toshihide Kurihara et al. JOURNAL OF CLINICAL INVESTIGATION
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- Vascular Endothelial Growth Factor Promotes Progressive Retinal Nonperfusion in Patients with Retinal Vein Occlusion
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Age and Gender Variations in Age-related Macular Degeneration Prevalence in Populations of European Ancestry: A Meta-analysis
- (2011) Alicja R. Rudnicka et al. OPHTHALMOLOGY
- Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey
- (2011) L. H. Vandenberghe et al. Science Translational Medicine
- The growing importance of pharmacoeconomics: the case of age-related macular degeneration
- (2010) A. F. Smith BRITISH JOURNAL OF OPHTHALMOLOGY
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
- (2010) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
- (2010) David M. Brown et al. OPHTHALMOLOGY
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
- Equine Infectious Anemia Viral Vector-Mediated Codelivery of Endostatin and Angiostatin Driven by Retinal Pigmented Epithelium-Specific VMD2 Promoter Inhibits Choroidal Neovascularization
- (2009) Shu Kachi et al. HUMAN GENE THERAPY
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia
- (2009) Sophie Rogers et al. OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The 15-Year Cumulative Incidence of Retinal Vein Occlusion
- (2008) Ronald Klein ARCHIVES OF OPHTHALMOLOGY
- Variation near complement factor I is associated with risk of advanced AMD
- (2008) Jesen A Fagerness et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels
- (2008) Shinji Ueno et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator
- (2008) Peter A Campochiaro et al. MOLECULAR THERAPY
- Intravenous Bevacizumab Causes Regression of Choroidal Neovascularization Secondary to Diseases Other Than Age-related Macular Degeneration
- (2007) Quan Dong Nguyen et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started